|
IPSC
|
Century Therapeutics, Inc.
|
US
|
NASDAQ
|
|
LGVN
|
Longeveron Inc.
|
US
|
NASDAQ
|
|
LYEL
|
Lyell Immunopharma, Inc.
|
US
|
NASDAQ
|
|
OCX
|
OncoCyte Corporation
|
US
|
NASDAQ
|
|
PEPG
|
PepGen Inc.
|
US
|
NASDAQ
|
|
PMVP
|
PMV Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
POAI
|
Predictive Oncology Inc.
|
US
|
NASDAQ
|
|
SQZ
|
SQZ Biotechnologies Company
|
US
|
NYSE
|
|
TCBP
|
TC BioPharm (Holdings) plc
|
US
|
NASDAQ
|
|
TTOO
|
T2 Biosystems, Inc.
|
US
|
NASDAQ
|
|
TYRA
|
Tyra Biosciences, Inc.
|
US
|
NASDAQ
|
|
CYP
|
Cynata Therapeutics Ltd
|
AU
|
ASX
|
|
EX1
|
Exopharm Limited
|
AU
|
ASX
|
|
MSB
|
Mesoblast limited
|
AU
|
ASX
|
|
RGS
|
Regeneus Ltd
|
AU
|
ASX
|
|
CYYNF
|
Cynata Therapeutics Ltd Ordinar
|
US
|
OTC
|
|
HMTXF
|
Hemostemix Inc
|
US
|
OTC
|
|
ISCO
|
International Stem Cell Corp
|
US
|
OTC
|
|
LGNDZ
|
Ligand Pharma
|
US
|
OTC
|
|
LGNXZ
|
Ligand Pharma
|
US
|
OTC
|